Your browser doesn't support javascript.
loading
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection.
Seidel, Alina; Jacobsen, Eva-Maria; Fabricius, Dorit; Class, Magdalena; Zernickel, Maria; Blum, Carmen; Conzelmann, Carina; Weil, Tatjana; Groß, Rüdiger; Bode, Sebastian F N; Renk, Hanna; Elling, Roland; Stich, Maximillian; Kirchhoff, Frank; Debatin, Klaus-Michael; Münch, Jan; Janda, Ales.
Afiliação
  • Seidel A; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
  • Jacobsen EM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Fabricius D; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Class M; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Zernickel M; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Blum C; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Conzelmann C; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
  • Weil T; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
  • Groß R; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
  • Bode SFN; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Renk H; University Children's Hospital Tuebingen, Tuebingen, Germany.
  • Elling R; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Faculty of Medicine, Institute for Immunodeficiency, University of Freiburg, Freiburg, Germany.
  • Stich M; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty for Medicine, University of Freiburg, Freiburg, Germany.
  • Kirchhoff F; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Debatin KM; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
  • Münch J; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm University, Ulm, Germany.
  • Janda A; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
Front Pediatr ; 11: 1020865, 2023.
Article em En | MEDLINE | ID: mdl-37051428
ABSTRACT

Introduction:

Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures.

Methods:

Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay.

Results:

We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children.

Discussion:

Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pediatr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pediatr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha